Sec Form 4 Filing - Velge Bertrand @ LifeMD, Inc. - 2019-09-30

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Velge Bertrand 2. Issuer Name and Ticker or Trading Symbol LifeMD, Inc. [ LFMD] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O LIFEMD, INC., 800 THIRD AVE STE 2800 3. Date of Earliest Transaction (MM/DD/YY) 09/30/2019 (Street) NEW YORK, NY10022 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 217,391( 1 ) D Common Stock 04/15/2020 P 294,118 A $ 0.17 511,509 D Common Stock 08/05/2020 A 173,234( 5 ) A $ 0 684,743 D Common Stock 09/22/2020 P 96,923 A $ 0.65( 3 ) 781,666 D Common Stock 12/03/2021 P 110,000 A $ 3.91( 2 ) 891,666 I By Aliunde LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Secur ities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrants to Purchase Common Stock $ 0.28 05/15/2019 05/15/2023 Common Stock 217,391 217,391 D Stock Option (Right to Buy) $ 1.15 09/30/2019 A 2,500( 4 ) 09/30/2019 09/30/2024 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 1.15 12/31/2019 A 2,500( 4 ) 12/31/2019 12/31/2024 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 1.2 03/31/2020 A 2,500( 4 ) 03/31/2021 03/31/2025 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 1.5 06/30/2020 A 2,500( 4 ) 06/30/2020 06/30/2025 Common Stock 2,500 $ 0 2,500 D Warrants to Purchase Common Stock $ 4.65 09/22/2020 A 100,000 09/22/2020 09/22/2024 Common Stock 100,000 $ 0 100,000 D Stock Option (Right to Buy) $ 7.95 09/30/2020 A 2,500( 4 ) 09/30/2020 09/30/2025 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 7 12/31/2020 A 2,500( 4 ) 12/31/2020 12/31/2025 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 11.98 03/31/2021 A 2,500( 4 ) 03/31/2021 03/31/2026 Common Stock 2,500 $ 0 2,500 D Stock Option (Right to Buy) $ 11.56 06/30/2020 A 2,500( 4 ) 06/30/2021 06/30/2026 Common Stock 2,500 $ 0 2,500 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Velge Bertrand C/O LIFEMD, INC. 800 THIRD AVE STE 2800 NEW YORK, NY10022 X Signatures /s/ Bertrand Velge 12/07/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock. ( 2 )The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. ( 3 )Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt. ( 4 )Issued as director's compensation. ( 5 )Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.